Processa Pharmaceuticals, Inc. (PCSA) › Operating IncomeProcessa Pharmaceuticals, Inc. (PCSA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$1.92M2017: -$1.80M2018: -$4.52M2019: -$3.94M2020: -$15.14M2021: -$12.13M2022: -$27.53M2023: -$11.46M2024: -$12.05M2025: -$13.99M-$13.99M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$13.99M-16.1%2024-$12.05M-5.2%2023-$11.46M+58.4%2022-$27.53M-126.9%2021-$12.13M+19.8%2020-$15.14M-284.6%2019-$3.94M+13.0%2018-$4.52M-151.0%2017-$1.80M+6.2%2016-$1.92M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share